For citations:
Fedina l.V., Sychev i.N., Mirzaev K.V., Vardanyan A.V., Glagolev S.V., Kachanova A.A., Bochkov P.O., Shevchenko R.V., Tuchkova S.N., Sychev I.V., Abdullaev S.P., Sychev D.A. Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis. Rational Pharmacotherapy in Cardiology. 2024;20(1):19-26. (In Russ.) https://doi.org/10.20996/1819-6446-2024-2941
Email this article 